# Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL

> **NCT03019666** · PHASE1 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 39 (actual)

## Conditions studied

- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Diffuse Large B Cell Lymphoma
- Mantle-Cell Lymphoma
- Follicular Lymphoma
- Indolent B Cell Lymphoma
- Primary Mediastinal Lymphoma
- Lymphoplasmacytic Lymphoma

## Interventions

- **BIOLOGICAL:** Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells

## Key facts

- **NCT ID:** NCT03019666
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-18
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-08-15
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03019666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03019666, "Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03019666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*